OptimizeRx (OPRX) Research & Development (2025 - 2026)
OptimizeRx (OPRX) posted Research & Development of $3.4 million for Q1 2026, down 31.76% sequentially from $5.0 million in Q1 2025, and down 31.76% YoY from $5.0 million in Q1 2025.
OptimizeRx (OPRX) Research & Development (2025 - 2026) Analysis & Trends
OptimizeRx has reported Research & Development for 2 years, with the latest figure at $3.4 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 26.83 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 56.79 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 81.41 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 99.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 50.38 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 45.05 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 30.58 Mn |
| 10 | OptimizeRx | 164.25 Mn | 140.15 Mn | 15.69 Mn | 5.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.53 Mn |
| Mar 31, 2026 | 3.40 Mn |
| Mar 31, 2025 | 4.99 Mn |